1 – 31 of 31
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2016
-
Mark
Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts.
(
- Contribution to journal › Article
-
Mark
TERT promoter mutations in melanoma survival.
(
- Contribution to journal › Article
- 2015
-
Mark
TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.
(
- Contribution to journal › Article
-
Mark
TERT promoter mutations in clear cell renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
(
- Contribution to journal › Article
-
Mark
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.
(
- Contribution to journal › Article
-
Mark
Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population.
(
- Contribution to journal › Article
-
Mark
Frequent DPH3 promoter mutations in skin cancers.
(
- Contribution to journal › Article
-
Mark
The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
(
- Contribution to journal › Article
-
Mark
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
(
- Contribution to journal › Article
- 2014
-
Mark
TERT promoter mutations in cancer development.
(
- Contribution to journal › Article
-
Mark
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
(
- Contribution to journal › Article
-
Mark
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
(
- Contribution to journal › Article
-
Mark
Inherited variation in the PARP1 gene and survival from melanoma
(
- Contribution to journal › Article
- 2013
-
Mark
Variants at the 9p21 locus and melanoma risk
(
- Contribution to journal › Article
-
Mark
Variants at chromosome 20 (ASIP locus) and melanoma risk
(
- Contribution to journal › Article
-
Mark
TERT Promoter Mutations in Familial and Sporadic Melanoma
(
- Contribution to journal › Article
-
Mark
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
(
- Contribution to journal › Article
-
Mark
Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
(
- Contribution to journal › Article
-
Mark
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
(
- Contribution to journal › Article
- 2012
-
Mark
Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database
(
- Contribution to journal › Article
- 2011
-
Mark
Familial bladder cancer and the related genes.
(
- Contribution to journal › Article
-
Mark
POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors
(
- Contribution to journal › Article
-
Mark
Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin
(
- Contribution to journal › Article
-
Mark
5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes.
(
- Contribution to journal › Article
-
Mark
MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case?control study from the Czech Republic
(
- Contribution to journal › Article
- 2010
-
Mark
Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients
(
- Contribution to journal › Article
-
Mark
Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood
(
- Contribution to journal › Article
-
Mark
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk
(
- Contribution to journal › Article